MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
0.570 (3.64%)
T-O (am): 0.565 (08:59:00)
Last updated: 16:59
iSaham Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
Quarter Reports
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Feb 23 | Q2 Dec 22 | 2 | 30 Jun 23 | 1.64 | -1.27 | -1.23 | -75.0% | 0.00 | -0.98 | 56.9% | 78.5% | 245.6% | 222.0% | ||||||||
| 23 Nov 22 | Q1 Sep 22 | 1 | 30 Jun 23 | 3.81 | 0.85 | 0.85 | 22.2% | 0.00 | 0.68 | 39.8% | 59.1% | 78.8% | 254.4% | ||||||||
| 30 Aug 22 | Q4 Jun 22 | 4 | 30 Jun 22 | 6.33 | 2.97 | 4.00 | 63.1% | 0.00 | 3.25 | 24.6% | 9278.3% | 103.5% | 289.7% | ||||||||
| 23 May 22 | Q3 Mar 22 | 3 | 30 Jun 22 | 5.08 | 1.96 | 1.96 | 38.6% | 0.00 | 1.60 | 33.4% | 212.2% | 94.3% | 882.0% | ||||||||
| 16 Feb 22 | Q2 Dec 21 | 2 | 30 Jun 22 | 7.63 | 1.01 | 1.01 | 13.2% | 0.00 | 0.83 | 18.1% | 5508.8% | 323.0% | 165.1% | ||||||||
| 30 Nov 21 | Q1 Sep 21 | 1 | 30 Jun 22 | 9.32 | 0.24 | 0.24 | 2.6% | 0.00 | 0.20 | 13601.5% | 10608.0% | 111.3% | 128.7% | ||||||||
| 23 Sep 21 | Q4 Jun 21 | 4 | 30 Jun 21 | -0.07 | -2.11 | -2.11 | 3052.2% | 0.00 | -1.94 | 104.2% | 2400.0% | 1153.0% | 61.3% | ||||||||
| 27 May 21 | Q3 Mar 21 | 3 | 30 Jun 21 | 1.63 | 0.20 | 0.20 | 12.3% | 0.00 | 0.19 | 1097.1% | 428.6% | 112.9% | 112.0% | ||||||||
| 18 Feb 21 | Q2 Dec 20 | 2 | 30 Jun 21 | 0.14 | -1.55 | -1.55 | -1142.7% | 0.00 | -1.50 | 56.3% | 97.3% | 86.5% | 106.4% | ||||||||
| 30 Nov 20 | Q1 Sep 20 | 1 | 30 Jun 21 | 0.09 | -0.83 | -0.83 | -957.5% | 0.00 | -0.80 | 2800.0% | 98.9% | 84.7% | 2424.2% | ||||||||
| 21 Aug 20 | Q4 Jun 20 | 4 | 30 Jun 20 | 0.00 | -2.61 | -5.44 | -181200.0% | 0.00 | -5.25 | 99.0% | 100.0% | 226.9% | 304.8% | ||||||||
| 22 May 20 | Q3 Mar 20 | 3 | 30 Jun 20 | 0.31 | -1.66 | -1.66 | -539.9% | 0.00 | -1.61 | 93.8% | 95.3% | 106.9% | 73.6% | ||||||||
| 18 Feb 20 | Q2 Dec 19 | 2 | 30 Jun 20 | 4.96 | 24.71 | 24.23 | 488.6% | 0.00 | 23.41 | 36.8% | 28.4% | 73530.3% | 2545.2% | ||||||||
| 19 Nov 19 | Q1 Sep 19 | 1 | 30 Jun 20 | 7.85 | 0.10 | -0.03 | -0.4% | 0.00 | -0.03 | 11.8% | 24.4% | 97.5% | 97.7% | ||||||||
| 27 Aug 19 | Q4 Jun 19 | 4 | 30 Jun 19 | 7.02 | -1.30 | -1.34 | -19.1% | 0.00 | -1.30 | 6.2% | 7.0% | 40.2% | 7.8% | ||||||||
| 24 May 19 | Q3 Mar 19 | 3 | 30 Jun 19 | 6.61 | -0.93 | -0.96 | -14.5% | 0.00 | -0.93 | 4.6% | 4.3% | 3.3% | 18.6% | ||||||||
| 22 Feb 19 | Q2 Dec 18 | 2 | 30 Jun 19 | 6.93 | -0.91 | -0.99 | -14.3% | 0.00 | -0.96 | 9.9% | 8.5% | 31.9% | 20.4% | ||||||||
| 24 Aug 18 | Q4 Jun 18 | 4 | 30 Jun 18 | 6.31 | -1.54 | -1.46 | -23.1% | 0.00 | -1.40 | 3.8% | 116.6% | 0.1% | 534.3% | ||||||||
| 24 May 18 | Q3 Mar 18 | 3 | 30 Jun 18 | 6.56 | -1.35 | -1.46 | -22.2% | 0.00 | -1.41 | 5.0% | 303.1% | 80.3% | 1301.0% | ||||||||
| 26 Feb 18 | Q2 Dec 17 | 2 | 30 Jun 18 | 6.91 | -0.69 | -0.81 | -11.7% | 0.00 | -0.78 | 8.2% | 237.6% | 1.8% | 71.5% | ||||||||
| 22 Nov 17 | Q1 Sep 17 | 1 | 30 Jun 18 | 6.38 | -0.79 | -0.82 | -12.9% | 0.00 | -0.80 | 119.2% | 94.2% | 345.7% | 199.3% | ||||||||
| 30 Aug 17 | Q4 Jun 17 | 4 | 30 Jun 17 | 2.91 | 0.39 | 0.34 | 11.5% | 0.00 | 0.32 | 79.0% | 57.3% | 422.1% | 193.9% | ||||||||
| 11 May 17 | Q3 Mar 17 | 3 | 30 Jun 17 | 1.63 | -0.09 | -0.10 | -6.4% | 0.00 | -0.10 | 20.5% | 9.0% | 77.9% | 145.6% | ||||||||
| 21 Feb 17 | Q2 Dec 16 | 2 | 30 Jun 17 | 2.05 | -0.46 | -0.47 | -23.0% | 0.00 | -0.46 | 37.8% | 35.9% | 156.8% | 196.3% | ||||||||
| 21 Nov 16 | Q1 Sep 16 | 1 | 30 Jun 17 | 3.29 | 0.83 | 0.83 | 25.2% | 0.00 | 0.88 | 77.6% | 8.7% | 627.2% | 8.5% | ||||||||
| 30 Aug 16 | Q4 Jun 16 | 4 | 30 Jun 16 | 1.85 | 0.12 | 0.11 | 6.2% | 0.00 | 0.12 | 3.5% | 44.8% | 50.0% | 76.1% | ||||||||
| 25 May 16 | Q3 Mar 16 | 3 | 30 Jun 16 | 1.79 | 0.23 | 0.23 | 12.8% | 0.00 | 0.24 | 44.0% | 58.4% | 53.4% | 82.4% | ||||||||
| 24 Feb 16 | Q2 Dec 15 | 2 | 30 Jun 16 | 3.19 | 0.49 | 0.49 | 15.3% | 0.00 | 0.52 | 11.2% | 13.5% | 46.0% | 63.9% | ||||||||
| 23 Nov 15 | Q1 Sep 15 | 1 | 30 Jun 16 | 3.60 | 0.91 | 0.91 | 25.2% | 0.00 | 0.96 | 7.3% | 40.8% | 89.9% | 82.3% | ||||||||
| 24 Aug 15 | Q4 Jun 15 | 4 | 30 Jun 15 | 3.35 | 0.48 | 0.48 | 14.2% | 0.00 | 0.51 | 21.9% | 67.8% | 63.2% | 103.8% | ||||||||
| 25 May 15 | Q3 Mar 15 | 3 | 30 Jun 15 | 4.29 | 1.30 | 1.30 | 30.2% | 0.00 | 1.38 | 16.2% | 914.9% | 4.2% | 166.1% | ||||||||
| 13 Feb 15 | 31/12/14 | 2 | 30/06/15 | 3.69 | 1.35 | 1.35 | 36.6% | 0.00 | 1.44 | 44.4% | 167.0% | 172.2% | 261.3% |
Historical Dividends
Financial Ratios
| EPS | 4.28 sen |
| Trailing PE (Sector Median: 20.0) | 13.3 |
| PEG | 13.3 |
| Altman Z | 1.6 |
| Beaver | -0.437 |
| Current Ratio | 21.18 |
| Debt-Equity (DE) Ratio | 1.11 |
| FCF Yield | -26.79 % |
| Revenue QoQ | -56.9 % |
| Revenue YoY | -78.46% |
| Profit QoQ | -245.57 % |
| Profit YoY | -221.96 % |
| Profit Margin (Sector Median: 4.2) | 33.04 % |
| ROE (ROIC: 13.71) | 13.71 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 20.0) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 4.2) | |
| ROE (ROIC: 13.71) | |
| Altman Z |
Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 1 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.31 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | -1.23 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
Directors Share Purchases (Beta)
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 2370000.0 units announced on 08 Aug 2022 at ~RM0.73
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 13 Jul 2022 at ~RM0.955
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 12 Jul 2022 at ~RM0.945
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19
TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05
TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885
TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83
TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78
Summary
Market Cap: 74 M.
Number of Shares: 130 M.
Adjusted Float: 83.8%.
Stock highly correlated with
MERIDIAN (95%)
KGROUP (93%)
XOXNET (93%)
AT (92%)
MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services
Sectors: Healthcare, Health Care Equipment & Services
Code: 0155
Website: http://www.mgrc.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
Top Shareholdings
Updated on 30-Sep-2021
| Shareholder | Value (M) |
|---|---|
| Phillip Securities (Hong Kong) Ltd | 5.87 |
| Liw Chai Yuk | 5.56 |
| Pixelvest Sdn Bhd | 3.49 |
| Chu Boon Lin | 2.85 |
| Goh Bian Soon | 2.0 |
| Kevin Tan Yean Khim | 1.88 |
| Saw Sooi Huat | 1.8 |
| Wong Wee Yong | 1.52 |
| Yeo Tsu Sin | 1.49 |
| Ping Hiow Yew | 1.27 |
| Mohd Rafael bin Mohd Shamsudin | 1.26 |
| Munirah binti Haji Abdul Hamid | 1.25 |
| Ooi Cyndy | 1.1 |
| Barclays Capital Securities Ltd | 0.98 |
| Ong San Leong | 0.85 |
| Liong Liuh Juin | 0.8 |
| Wong Chen How | 0.79 |
| Nor Azah binti Adnan | 0.74 |
| Foo Chai Lee | 0.7 |
| Albert Tan Yean Heong | 0.69 |
| Inertia Aif Sdn Bhd | 0.67 |
| Noraziah binti Adnan | 0.66 |
| Khoo Hai Chew | 0.57 |
| Shahril bin Shamsuddin | 0.57 |
| Societe Generale Paris | 0.55 |
| Choong Chee Yip | 0.47 |
| Tan Kok Aun | 0.47 |
Social
